Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at JMP Securities from $85.00 to $83.00. They now have a "market outperform" rating on the stock.
Prothena Co. plc (NASDAQ: PRTA) had its price target lowered by analysts at HC Wainwright from $90.00 to $84.00. They now have a "buy" rating on the stock.
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses [Yahoo! Finance]
Prothena Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
Prothena Reports First Quarter 2024 Financial Results and Business Highlights